| Literature DB >> 20161845 |
Vandana Kumari1, Chenglong Li.
Abstract
Glucokinase (GK) is expressed in multiple organs and plays a key role in hepatic glucose metabolism and pancreatic insulin secretion. GK could indeed serve as pacemaker of glycolysis and could be an attractive target for type 2 diabetes (T2D). The recent preclinical data of first GK activator RO-28-1675 has opened up a new field of GK activation as a powerful tool in T2D therapies. The GK allosteric site is located ~20A away from glucose binding site. Chemical structure of Glucokinase activators (GKA) includes three chemical arms; all consisting of cyclic moiety and joined in a shape resembling the letter Y. In this study, comparative docking assessment using Autodock4 revealed that the three arms bind to three aromatic/hydrophobic subpockets at the allosteric site. Our dockings have overall consistency with experimental data in both docking modes and simulated binding free energies, and offer insights on understanding GK/GKA interactions and further GKA design. Specifically, for the first pocket, involvement of Arg63 as key residue in two specific hydrogen-bond formations with all allosteric activators defines the binding feature; for the second pocket, it has the most diverse binding interactions, mostly aromatic, hydrophobic and multiple hydrogen bonds. The site has the best potential for further GKA optimization by utilizing aromatic heterocycles and hydrogen bond forming linkers to build the GKA 2(nd) arm.Entities:
Keywords: Allosteric; AutoDock; Drug design.; Free energy; GKA; Glucokinase activator; Molecular docking; Molecular recognition; glucokinase
Year: 2008 PMID: 20161845 PMCID: PMC2803441 DOI: 10.2174/1875397300802010076
Source DB: PubMed Journal: Curr Chem Genomics ISSN: 1875-3973
Fig. (7)Binding mode of class II GKAs. A. Aligned binding mode of class II GKAs. B. Binding mode of ligand 9 at the allosteric site of GK, there is additional H bond formation between Arg63 side chain and the ligand.
| A: Class I: Amide-Based Chiral GKAs | |||||
|---|---|---|---|---|---|
| Ligand | R1 | R2 | R3 | Estimated Free Energy of Binding, ∆Gbind (kcal/mol) | Exp. EC50(µM) |
| 1. | -9.2 | - | |||
| 2. | -9.1 | - | |||
| 3. | -9.5 | - | |||
| 4. | -10.3 | - | |||
| 5. | -12.0 | - | |||
| 6. | -9.2 | - | |||
| 7. | -9.7 | 0.13 | |||
| 8. | -7.4 | - | |||
| 9. | -9.4 | 0.09 | |||
| 10. | -8.9 | 0.57 | |||
| 11. | -8.9 | - | |||
| 12. | -9.0 | - | |||
| 13. | -9.1 | 0.16 | |||
| 14. | -10.1 | - | |||
| 15. | -9.5 | - | |||
| 16. | -9.3 | 16.0 | |||
| 17. | -9.7 | 6.0 | |||
| 18. | -8.5 | 3.2 | |||
| 19 | -9.3 | 0.16 | |||
| 20. | -8.2 | 0.14 | |||
| 21. | -7.7 | 0.91 | |||
| 22. | -8.9 | - | |||
Reference 9 for EC50 value.
Reference 10 for EC50 value.
Reference 12 for EC50 value.
Reference 14 for EC50 value.
Reference 16 for EC50 value.
Allosteric Amino Acid Residues Involved in the Binding Interactions with the Ligands
| Residues involved in hydrogen bond | Residues involved in hydrophobic interaction (small domain) | Residues involved in hydrophobic interaction (large domain) |
|---|---|---|
| Arg63, Tyr215, Gln98 | Val452, Val455, Ala456 | Val62, Pro66, Ile159, Met210,Ile211, Tyr214, Met235, Cys220 |
Binding Free Energy Comparison Between the Experimentala Values and AutoDock’s Predicted Values of the Ligands. Experimental Values are Converted from EC50 Values in Table 1
| Ligands | Binding free energy (∆Gbind) (kcal/mol) | |
|---|---|---|
| AutoDock (predicted) | Experimental | |
| 7 | -9.7 | -9.3 |
| 9 | -9.4 | -9.6 |
| 10 | -9.0 | -8.5 |
| 13 | -9.1 | -9.2 |
| 16 | -9.3 | -6.5 |
| 17 | -9.7 | -7.1 |
| 18 | -8.5 | -7.5 |
| 19 | -9.3 | -9.2 |
| 20 | -8.2 | -9.2 |
| 21 | -7.7 | -8.2 |
Histogram Showing Experimental and Autodock Predicted Binding Energies (kcal/mol) for Ligands